Exciting news from Aurinia at EULAR 2024! Discover the latest on LUPKYNIS® safety and efficacy.
Aurinia, the renowned pharmaceutical company, made waves at the European Alliance of Associations for Rheumatology (EULAR) 2024 with a groundbreaking presentation on LUPKYNIS®, their innovative lupus treatment. The presentation highlighted the safety and efficacy profile of LUPKYNIS®, marking a significant milestone in lupus management. Attendees were captivated by the promising data shared by Aurinia, showcasing the potential of LUPKYNIS® to revolutionize the treatment landscape for lupus patients.
The audience was particularly impressed by Aurinia's commitment to advancing lupus research and providing cutting-edge solutions for patients. The presentation at EULAR 2024 demonstrated Aurinia's dedication to improving the lives of individuals affected by this complex autoimmune disease. LUPKYNIS® emerged as a beacon of hope in the fight against lupus, offering a glimpse into a future where better therapeutic options are within reach.
In conclusion, Aurinia's unveiling of the safety and efficacy profile of LUPKYNIS® at EULAR 2024 signifies a significant step forward in the field of lupus treatment. The event not only showcased Aurinia's expertise and innovation but also emphasized the company's relentless pursuit of excellence in addressing unmet medical needs. With LUPKYNIS® on the horizon, the future looks promising for lupus patients worldwide.
(NASDAQ: AUPH) (Aurinia or the Company), today announced an oral presentation at the European Alliance of Associations for Rheumatology (EULAR) 2024 taking ...
An eGFR cutoff of 75 mL/min/1.73 m2 after 1 year of treatment was predictive of progression to chronic kidney disease among patients with lupus nephritis.
Investigators followed children with lupus nephritis for a decade or more to identify initial predictors of kidney disease and failure (ESKD).
The singer hinted at a diagnosis on social media. Selena Gomez has also been public about having lupus.
Although the 29-year-old did not identify her conditions, she hinted in an Instagram post she'd been diagnosed with lupus and leukaemia. In a series of photos ...
Singer Halsey, 29, hinted at a recent health battle with lupus, a 'sneaky' autoimmune condition that causes the body to attack itself.
“In 2022, I was first diagnosed with Lupus SLE and then a rare T-cell lymphoproliferative disorder. Both of which are currently being managed or in remission; ...
Celebrities with lupus, including Selena Gomez and Nick Cannon, share their experiences in order to raise awareness about the chronic condition.
It affects one in one thousand Canadians and anyone can get it, but women between 15 and 45 years old are most affected, Lupus Canada says.
Halsey is currently managing recent diagnoses of Lupus SLE and a 'rare T-cell lymphoproliferative disorder'
Grammy-nominated singer and songwriter, Halsey, shared a big news update regarding her health—and her music—on Wednesday. The electric pop singer took to ...
Patients at the Cleveland Clinic are part of a clinical trial for a new way to treat lupus.
Lupus is an autoimmune disease in which the body's immune system attacks healthy cells leading to pain, fever, rashes, organ damage and other symptoms. T-cells ...
"You've all been so kind so I want to share a bit more," she wrote on Instagram.
Halsey opened up about her lupus and "rare" lymphoproliferative disorder diagnosis after dropping her new song "The End."
In an Instagram post Wednesday, the “MaXXXine” actress revealed “in 2022, I was first diagnosed with Lupus SLE and then a rare T-cell lymphoproliferative ...
T-cells are a type of immune cell, and lymphoproliferative disorders are conditions that cause the body to make uncontrolled amounts of white blood cells called ...
Grammy-nominated singer and songwriter, Halsey, shared a big news update regarding her health—and her music—on Wednesday. The electric pop singer took to ...
The singer announced her fifth album amid severe health struggles.
Thanks to the loving support from her fans, Halsey has opened up about her struggle with chronic illness and her journey toward recovery.
The singer revealed that she was diagnosed with Lupus SLE and then a rare T-cell lymphoproliferative disorder in 2022. In a new Instagram post, Halsey said that ...
Following the release of The End, Halsey wants to “share a bit more” about being diagnosed with “Lupus SLE and then a rare T-cell lymphoproliferative…
On Wednesday, the singer revealed that in 2022, they were diagnosed with lupus SLE and a rare T-cell lymphoproliferative disorder. Systemic lupus erythematosus, ...
While announcing her fifth studio album and releasing its lead single, The End, Halsey, 29, said on Instagram: "Long story short, I'm lucky to be alive. Short ...
The “Without Me” singer revealed that she was first diagnosed with Lupus SLE and a rare T-cell lymphoproliferative disorder in 2022. Lupus is a chronic ...
On Instagram this week, the singer revealed they were diagnosed with lupus and a rare T-cell disorder in 2022. The singer also released a new acoustic ...
Inflammatory cell infiltration is commonly seen in kidney biopsies from patients with lupus nephritis. In a retrospective study of 430 patients with lupus ...
“In 2022, I was first diagnosed with Lupus SLE and then a rare T-cell lymphoproliferative disorder. Both of which are currently being managed or in remission; ...